Atrys is a global healthtech company that provides medical services that maximise efficiency in prevention, diagnosis and precision medical treatment through innovative technologies. It is a pioneer in telemedicine and oncology treatment. It has a team of more than 2,400 professionals, is present in seven countries in Europe and Latin America, and is the only listed company in the healthcare technology sector in Spain.

The company structures its activity around two main business areas. On one side, precision medicine, which includes diagnostics (telemedicine, nuclear medicine, pathology and molecular anatomy) and oncology treatment (medical oncology and advanced radiotherapy); and on the other, preventive medicine, dedicated to prevention and health promotion, which serves more than one million people through its network of more than 200 branches.

  • Area of Activity
  • Technology transfer
  • Gene Therapy
  • Cellular Therapy
  • Research services and supplies
  • Diagnostic tests
  • Oftalmology
  • Internet and information technologies
  • Training
  • Manufacture of biotech equipment
  • Clinical trials
  • Diagnostic - Imaging
  • Software development
  • Biotechnology kits
  • Dermatology
  • Cancer
  • Cardiovascular and circulatory system
  • Cellular and molecular biology
  • Company type
  • Services and consulting for biotech sector
  • Health Biotechnology
  • Technology Services
  • Industrial Biotechnology - Manufacturers
C/ Príncipe de Vergara 132, 1º piso
Madrid , Madrid 28002, ES
P: +34 917 819 465
F:+34 91 5776744
Atrys Diagnóstico Provença. C/Provença 392, planta baixa
Barcelona, Barcelona 08025, ES
P: +34 902 109 053
Atrys Diagnóstico Teknon. C/ Vilana 12, planta -2
Barcelona, Barcelona 08022, ES
P: +34 932 906 283
Atrys Oncología IMOR. C/ Escuelas Pias nº 81
Barcelona, Barcelona 08017, ES
P: +34 932 531 670
Atrys Oncología IOA. Hospital CIMA. Paseo Manuel Girona 23
Barcelona, Barcelona 08034, ES
P: +34 932 534 408
Atrys Diagnóstico Balmes. C/ Balmes 317, Entresuelo 2º
Barcelona, Barcelona 08006, ES
P: +34 933 620 590
Atrys Sardenya. C/ Sardenya 229 6-4,
Barcelona, Barcelona 08013, ES
P: +34 934 581 561
SIMM Molecular. C/ Josep Irla i Bosch, 5, Local 2
Barcelona, Barcelona 08034, ES
P: +34 932 540 470
Atrys Diagnóstico Lugo. Parque Empresarial As Gándaras, Rúa María Barbeito 61
Lugo, Lugo 27003, ES
P: +34 982 240 944
Atrys Granada. Edificio Genyo (PTCS), Avenida Ilustración 114
Granada, Granada 18007, ES
P: +34 958 715 500
Bienzobas. Calle Juan Bravo 51 duplicado, 1º izquierda
Madrid, Madrid 28006, ES
P: +34 900 103 363 / +34 900 102 053
ASPY Prevención – Red de centros. Vial del les Pedreres Nave E-1
Montgat, Barcelona 08390, ES
P: +34 900 120 124

The management team consists of scientists and senior managers with a solid career in the field of health. In total, Atrys has now 30 professionals specializing in oncology.

De Torres Sanahuja, Santiago - Executive President
Lozano Fernández, Isabel - CEO
Huch Ginesta, José María - CFO
Giró, Antonio - Managing Director Diagnostics
Isach, Marian Isach - Managing Director Oncology

Sánchez, Sara - Managing Director Prevention

Within the diagnostics business other than in the area of oncology, Atrys uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology and dermatology, using its own technology platform. This activity benefits Atrys's business relationship with stakeholders in the health sector, in a simmilar manner as in the field of oncology.

Precision Medicine
Preventive Medicine
Occupational Medicine
Smart Data
Diagnostic Tests
Diagnostic Imaging
Medical and Radiation Oncology
Clinical trials
R&D projects

Research conducted by the team of Atrys in collaboration with international medical centers of academic excellence has produced results indicating that Single Dose high intensity radiation treatments allow to activate different biological mechanisms for tumor cure that are not activated with conventional radiotherapy.

The company model includes a molecular diagnostic methodology for individual tumor phenotyping that generates information that allows the specialist to identify which clinical approach is more appropriate for each patient and, in particular, to identify those who can benefit from the single-dose stereotactic body radiation therapy (SD-SBRT or Single dose radiotherapy).

Atrys is born with the mission to help people live healthier lives with a prolonged life expectancy.

To do this, it seeks to facilitate access to medical diagnosis and treatments of excellence, overcoming physical location barriers between doctor and patient specialist.

Atrys Health